Neuroleptic dosing in Hispanic and Asian inpatients with schizophrenia

Mount Sinai Journal of Medicine

Volumn 63, Issue 5-6, 1996, Pages 310-313

  Collazo, Yasmine ^a   Tam, Raymond ^a   Sramek, John ^a   Herrera, John ^a,b  

^a ELMHURST HOSPITAL CENTER   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT;

ADULT; ARTICLE; ASIAN AMERICAN; CLINICAL ARTICLE; CONTROLLED STUDY; ETHNIC GROUP; FEMALE; HUMAN; MALE; SCHIZOPHRENIA;

ADULT; ANALYSIS OF VARIANCE; ANTIPSYCHOTIC AGENTS; CROSS-CULTURAL COMPARISON; ETHNIC GROUPS; FEMALE; HISPANIC AMERICANS; HUMANS; MALE; OUTPATIENTS; RETROSPECTIVE STUDIES; SCHIZOPHRENIA; UNITED STATES;

EID: 0029834062     PISSN: 00272507     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Okuma T. Differential sensitivity to the effects of psychotropic drugs: Psychotics vs normals; Asians vs Western populations. Folia Psychiatr Neurol Jpn 1981; 35:79-82.
2. Olatawara M. The effects of psychotropic drugs in different populations. Bull WHPP 1978; 56:519-523.
3. Yamamoto J, Fung D, Lo S, et al Psychopharmacology for Asian Americans and Pacific Islanders. Psychopharmacol Bull 1979; 15:29-31.
4. Lin K, Finder E. Neuroleptic dosage for Asians. Am J Psychiatry 1983; 140:490-491.
5. Rosenblatt R, Tang S. Do Oriental psychiatric patients receive different dosages of psychotropic medication when compared with Occidentals? Can J Psychiatry 1987; 32:270-274.
6. Potkin S, Shen Y, Pardes H, et al. Haloperidol concentrations elevated in Chinese patients. Psychiatry 1984; 12: 167-172.
7. Davis J. Dose equivalence of the antipsychotic drugs. J Psychiatr Res 1974; 11:65-69.
8. Janicak P, Javaid R, Sharma A, et al. Random assignment to three haloperidol plasma levels for acute psychosis. Biol Psychiatry 1994; 35:666.
9. Stone C, Garver D, Griffith J, et al. Further evidence of a dose-response threshold for haloperidol in psychosis. Am J Psychiatry 1995; 152:1210-1212.
10. Wode-Helgodt B, Borg S, Fyro B, Sedvall G. Clinical effects and drug concentrations in plasma and cerebrospinal fluid in psychotic patients treated with fixed doses of chlorpromazine. Acta Psychiatr Scand 1978; 58:149-173.